Analysis: Watson for Oncology was over-marketed, now underwhelms hospitals and oncologists

(By Jessica Kim Cohen for Becker’s Hospital Review)

The artificial intelligence platform Watson for Oncology hasn’t met the high expectations its developers at IBM laid out, according to an  analysis  by STAT writers Casey Ross and Ike Swetlitz.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link's validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.